These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 26165271
1. Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivo. Leng XH, Chen EQ, Du LY, Bai L, Gong DY, Cheng X, Huang FJ, Tang H. Mol Med Rep; 2015 Oct; 12(4):5141-8. PubMed ID: 26165271 [Abstract] [Full Text] [Related]
2. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators. Raney AK, Kline EF, Tang H, McLachlan A. Virology; 2001 Oct 25; 289(2):239-51. PubMed ID: 11689047 [Abstract] [Full Text] [Related]
3. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trépo C, Wands J, Tong S. J Virol; 2003 Jun 25; 77(12):6601-12. PubMed ID: 12767980 [Abstract] [Full Text] [Related]
4. A new hepatitis B virus e antigen-negative strain gene used as a reference sequence in an animal model. Cao M, Zhao Z, Tang Y, Wei Q, Wang L, Xiang Q, Zhang Y, Zhang H, Lai G. Biochem Biophys Res Commun; 2018 Feb 05; 496(2):502-507. PubMed ID: 29339154 [Abstract] [Full Text] [Related]
5. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir. Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V. Antivir Ther; 2004 Jun 05; 9(3):353-63. PubMed ID: 15259898 [Abstract] [Full Text] [Related]
6. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation. Wang Y, Wei L, Jiang D, Cong X, Fei R, Chen H, Xiao J, Wang Y. Antiviral Res; 2007 Aug 05; 75(2):139-45. PubMed ID: 17397939 [Abstract] [Full Text] [Related]
7. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants. Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C. J Virol; 2004 Aug 05; 78(16):8524-35. PubMed ID: 15280461 [Abstract] [Full Text] [Related]
8. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains. Amini-Bavil-Olyaee S, Herbers U, Luedde T, Trautwein C, Tacke F. J Viral Hepat; 2011 Nov 05; 18(11):804-14. PubMed ID: 20887378 [Abstract] [Full Text] [Related]
9. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe. Tu WH, Lv Y, Zhang YM, Hou W, Wang JY, Zhang YJ, Liu HY, Zhu HX, Qin YL, Mao RC, Zhang JM. World J Gastroenterol; 2015 Jun 07; 21(21):6639-48. PubMed ID: 26074702 [Abstract] [Full Text] [Related]
10. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard MJ, Zoulim F, Plumas J, Aspord C. Hepatology; 2012 Nov 07; 56(5):1706-18. PubMed ID: 22707082 [Abstract] [Full Text] [Related]
11. Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes. Cui XJ, Cho YK, Song BC. J Med Virol; 2015 Apr 07; 87(4):601-8. PubMed ID: 25612255 [Abstract] [Full Text] [Related]
12. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Huang H, Zhou W, Zhu H, Zhou P, Shi X. Toxicol Appl Pharmacol; 2017 May 15; 323():36-43. PubMed ID: 28322895 [Abstract] [Full Text] [Related]
13. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. Zheng Y, Li J, Ou JH. J Virol; 2004 Jul 15; 78(13):6908-14. PubMed ID: 15194767 [Abstract] [Full Text] [Related]
14. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients. Huang YH, Wu JC, Chang TT, Sheen IJ, Huo TI, Lee PC, Su CW, Lee SD. J Viral Hepat; 2006 May 15; 13(5):336-42. PubMed ID: 16637865 [Abstract] [Full Text] [Related]
16. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients. Yan CH, Zhao CY, Ding H, Peng YQ, Jin PY, Yan L, Zhuang H, Li T. Antiviral Res; 2012 Nov 15; 96(2):108-14. PubMed ID: 22960603 [Abstract] [Full Text] [Related]
17. Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy. Hung CH, Chen CH, Lu SN, Wang JH, Hu TH, Huang CM, Tsai MC, Lee CM. Antiviral Res; 2012 Jan 15; 93(1):55-63. PubMed ID: 22061616 [Abstract] [Full Text] [Related]
18. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Günther S, Paulij W, Meisel H, Will H. Virology; 1998 Apr 25; 244(1):146-60. PubMed ID: 9581787 [Abstract] [Full Text] [Related]
19. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure. Xiao L, Zhou B, Gao H, Ma S, Yang G, Xu M, Abbott WG, Chen J, Sun J, Wang Z, Hou J. J Med Virol; 2011 Sep 25; 83(9):1544-50. PubMed ID: 21739444 [Abstract] [Full Text] [Related]
20. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, Tacke F. Hepatology; 2009 Apr 25; 49(4):1158-65. PubMed ID: 19263474 [Abstract] [Full Text] [Related] Page: [Next] [New Search]